Moreover, increased AREG expression may be linked to cisplatin resistance in mammary cancer [17] and HepG2 hepatoma cell lines [18], but not in pulmonary cancer [17] or HNSCC cell lines [19]. This evidence concerns the gene AREG and breast cancer.